Cyclophosphamide Injection, Powder, For Solution
Product Images NDC 70436-106

This text is a detailed pharmaceutical description for Cyclophosphamide for Injection, USP. It includes information on dosage, reconstitution, storage, and dilution requirements for intravenous use. The product is identified by the NDC code 70436-105-80 and contains 500 mg of cyclophosphamide and 375 mg of mannitol per vial. Additionally, it emphasizes that it is a hazardous drug and provides caution on the type of solutions that can be used for dilution. The pharmaceutical company Slate Run Pharmaceuticals is mentioned as the distributor, with manufacturing details from Hainan Poly Pharm. Co., Ltd. in China.*

This text provides essential details about a product labeled as Cyclophosphamide for Injection, USP. It includes information about the manufacturer, distributor, dosage, administration instructions, and storage requirements. This drug is designated as a hazardous substance and requires proper handling and disposal procedures. The text specifies that the vial contains 1 gram of cyclophosphamide and 750 mg of mannitol. Additionally, it outlines the permissible solutions for dilution before intravenous infusion and emphasizes that only specific types of injections should be used for dilution. The text also provides crucial contact information for both the manufacturer and the distributor.*

This is a description of Cyclophosphamide for Injection, USP. Manufactured in China by Hainan Poly Pharm. Co., Ltd. and distributed by Slate Run Pharmaceuticals, Inc. in Ohio. Each vial contains 2g Cyclophosphamide and 1500mg mannitol. It is a hazardous drug that should be stored at or below 25°C (77°F). After reconstitution, it can be used for direct intravenous injection or further diluted before intravenous infusion. Specific caution is advised for dilution using particular solutions. Please refer to the prescribing information for complete dosage and administration instructions.*